FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study

Widespread adoption of primary human papillomavirus (HPV)‐based screening has encouraged the search for a triage test which retains high sensitivity for the detection of cervical cancer and precancer, but increases specificity to avoid overtreatment. Methylation analysis of FAM19A4 and miR124‐2 gene...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Cancer
Autori principali: Vink, Frederique J., Meijer, Chris J.L.M., Clifford, Gary M., Poljak, Mario, Oštrbenk, Anja, Petry, Karl Ulrich, Rothe, Beate, Bonde, Jesper, Pedersen, Helle, de Sanjosé, Silvia, Torres, Montserrat, del Pino, Marta, Quint, Wim G.V., Cuschieri, Kate, Boada, Elia Alcañiz, van Trommel, Nienke E., Lissenberg‐Witte, Birgit I., Floore, Arno N., Hesselink, Albertus T., Steenbergen, Renske D.M., Bleeker, Maaike C.G., Heideman, Daniëlle A.M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2019
Soggetti:
Tumor Markers and Signatures
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7383900/
https://ncbi.nlm.nih.gov/pubmed/31390052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32614
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi